Author:
Gardner Alexander,Barbieri Joseph T.
Publisher
Springer International Publishing
Reference49 articles.
1. Arnon, S. S., et al. (2006). Human botulism immune globulin for the treatment of infant botulism. The New England Journal of Medicine, 354(5), 462–471. https://doi.org/10.1056/NEJMoa051926
2. Azarnia Tehran, D., et al. (2017). Hsp90 is involved in the entry of clostridial neurotoxins into the cytosol of nerve terminals. Cellular Microbiology, 19(2). https://doi.org/10.1111/cmi.12647
3. Binz, T., et al. (2002). Arg(362) and Tyr(365) of the botulinum neurotoxin type A light chain are involved in transition state stabilization. Biochemistry, 41(6), 1717–1723. https://doi.org/10.1021/bi0157969
4. Brunt, J., et al. (2018). Identification of a novel botulinum neurotoxin gene cluster in Enterococcus. FEBS Letters, 592(3), 310–317. https://doi.org/10.1002/1873-3468.12969
5. Center for Disease Control and Prevention. (2011). Notice of CDC’s Discontinuation of Investigational Pentavalent (ABCDE) Botulinum Toxoid Vaccine for Workers at Risk for Occupational Exposure to Botulinum Toxins. MMWR. Morbidity and Mortality Weekly Report, 60(42), 1454–1455.